Brief: iNtRON Biotechnology receives patent
28/11/2017 02:22
Nov 28 (Reuters) - iNtRON Biotechnology Inc 048530.KQ :
* Says it received patent on Nov. 27, for pharmaceutical
composition containing fk506 derivative for treating fungal
infection caused by genus cryptococcus and genus candida and use
thereof
Source text in Korean: https://goo.gl/QmHseK
Further company coverage: 048530.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))